IP Library Granted Patent US 7,208,314
Granted Patent B2
US 7,208,314 · App. 10/083,456 · Granted Apr 24, 2007

Compositions and methods for drug delivery using pH sensitive molecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,208,314
App. No.
10/083,456
Granted
Apr 24, 2007
Kind
B2
Abstract

A system relating to the delivery of desired compounds (e.g., drugs and nucleic acids) into cells using pH-sensitive delivery systems. The system provides compositions and methods for the delivery and release of a compound to a cell.

Claims (14)

1. A non-viral complex for delivering a nucleic acid to a cell, comprising:

a) a membrane-active compound capable of disrupting membranes covalently attached to an interaction modifier via a labile bond;

b) a polymer; and,

c) the nucleic acid.

2. A non-viral complex for transfecting a cell, comprising:

a) a polymer containing a plurality of membrane-active compounds capable of disrupting membranes wherein the membrane active compounds are attached to the polymer via labile bonds;

b) a polycation polymer containing a labile bond; and,

c) the nucleic acid.

3. The complex of claim 1 wherein the polymer contains a labile linkage.

4. The complex of claim 2 wherein the polycation polymer is attached to the membrane-active compound by the labile linkage.

5. The complex of claim 1 wherein the polymer inhibits the polymeric membrane-active compound.

6. The complex of claim 1 or 2 wherein the labile linkage is selected from the group consisting of pH-labile, a pH-labile bond with a half-life of less than 45 minutes at pH 5, a pH labile bond with a half-life of less than 15 minutes at pH 5.

7. The complex of claim 1 or 2 wherein the labile linkage is selected from the group consisting of disulfide, acetal, ketal, enol ether, enol ester, amide, imine, imminium, enamine, silyl ether, silazane, and silyl enol ether bonds.

8. The complex of claim 1 or 2 wherein the labile linkage is selected from the group consisting of diols, diazo, ester, sulfone, and silicon-carbon bonds.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 8, 2024
From: ARROWHEAD MADISON INC.
To: ARROWHEAD PHARMACEUTICALS, INC.
Reel/Frame 068227/0973 →
SECURITY INTEREST Recorded Aug 7, 2024
From: ARROWHEAD PHARMACEUTICALS, INC.
To: SIXTH STREETLENDING PARTNERS, AS THE ADMINISTRATIVE AGENT
Reel/Frame 068510/0363 →
CHANGE OF NAME Recorded Feb 26, 2014
From: ROCHE MADISON INC.
To: ARROWHEAD MADISON INC.
Reel/Frame 032302/0843 →